@article{b90b41c7a468455ba19569096e583394,
title = "Vinorelbine Plus Capecitabine in a Heavily Pretreated HER2 Negative Metastatic Breast Cancer Patient Population: MCEPASTEBIN",
author = "Reshma Mahtani and A. Torres and C. Vogel and J. Ramdial and A. Sandoval-Leon",
note = "e13122 Background: Metastatic breast cancer (MBC) is viewed as essentially incurable. Even though some studies have shown survival benefit for combination chemotherapy they were not specifically designed to address the superiority of combination versus sequential chemotherapy.",
year = "2018",
language = "American English",
volume = "36",
journal = "Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting",
}